Dawnrays Pharmaceutical Holdings Ltd. (HK:2348) has released an update.
Dawnrays Pharmaceutical (Holdings) Limited has announced successful passage of all proposed resolutions during its Annual General Meeting held on 24 May 2024, with unanimous approval on several key motions including the declaration of a final dividend and the reappointment of auditors. Shareholders were in strong favor of the resolutions with significant majority votes, indicating solid support for the company’s strategic decisions and board recommendations.
For further insights into HK:2348 stock, check out TipRanks’ Stock Analysis page.
